Synergistic Multi-Channel RF Ablation System with Integrated AI, IoT, Blockchain, and Advanced Materials

Publication ID: 24-11857245_0003_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Multi-Channel RF Ablation System with Integrated AI, IoT, Blockchain, and Advanced Materials,” Published Technical Disclosure No. 24-11857245_0003_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857245_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,245.

Summary of the Inventive Concept

The invention integrates multi-channel RF ablation with AI, IoT, blockchain, and advanced materials to create a more effective and efficient treatment system for cardiac arrhythmias, offering real-time monitoring, personalized treatment, and enhanced safety.

Background and Problem Solved

The original patent described a multi-channel RF ablation method, but it lacked real-time monitoring and adaptation capabilities, limited its applicability and effectiveness. The new inventive concept addresses these limitations by incorporating synergistic technologies to provide a more comprehensive and adaptive treatment system.

Detailed Description of the Inventive Concept

The system consists of a control signal generator, an ablation signal generator, a combiner, and one or more of the following modules: AI-based monitoring, IoT-enabled sensors, blockchain-based data storage, and new materials-based electrodes. The AI module analyzes the control signals and adjusts the ablation signals in real-time, while the IoT sensors monitor the subject's physiological response and provide feedback for adjustment. The blockchain module securely stores and manages the subject's treatment data, ensuring data integrity and confidentiality. The new materials-based electrodes provide enhanced tissue contact and reduced thermal spread, improving treatment outcomes.

Novelty and Inventive Step

The new inventive concept combines the original multi-channel RF ablation method with distinct technologies, creating a synergistic system that provides real-time monitoring, personalized treatment, and enhanced safety. The integration of AI, IoT, blockchain, and advanced materials constitutes a novel and non-obvious improvement over the original patent.

Alternative Embodiments and Variations

Alternative embodiments may include varying the AI algorithm, using different IoT sensor configurations, or incorporating other advanced materials for electrodes. Variations may also include adapting the system for other medical applications, such as cancer treatment or pain management.

Potential Commercial Applications and Market

The Synergistic Multi-Channel RF Ablation System has significant commercial potential in the medical device industry, particularly in the cardiac arrhythmia treatment market. The system's real-time monitoring and adaptation capabilities, combined with its enhanced safety features, make it an attractive solution for hospitals and medical centers.

CPC Classifications

SectionClassGroup
A A61 A61B18/1206
A A61 A61B18/1492
A A61 A61B2018/00351
A A61 A61B2018/00577
A A61 A61B2018/00702
A A61 A61B2018/00732
A A61 A61B2018/00767
A A61 A61B2018/00791
A A61 A61B2018/00827
A A61 A61B2018/00875
A A61 A61B2018/00892
A A61 A61B2018/128
A A61 A61B2018/1273

Field of Art

Medical device technologies for radiofrequency ablation, specifically cardiac tissue treatment, involving multi-channel signal generation, modulation, and therapeutic signal application with expertise in biomedical engineering, electrical signal processing, and medical intervention techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device researcher with advanced electrical engineering skills, knowledge of RF ablation techniques, signal modulation principles, and experience developing medical intervention technologies with interdisciplinary technical capabilities

Obviousness Rationale

A PHOSITA would recognize that integrating contemporary technologies like AI, IoT, and blockchain into the existing multi-channel RF ablation framework represents a predictable technological evolution that enhances monitoring, personalization, and data management without fundamentally altering the core signal generation and ablation methodology disclosed in the source patent.

Obvious Combinations & Variations

Source Patent Element
Multi-channel RF ablation with control signals having different frequencies
PTD Variation
Adding AI-based monitoring module to dynamically adjust ablation signals based on real-time physiological response
Obviousness Reasoning
Adaptive signal modulation is a known technique in medical device technologies, and applying machine learning to optimize therapeutic parameters represents a predictable application of contemporary AI techniques
Source Patent Element
Generating composite signals for application to cardiac tissue
PTD Variation
Incorporating IoT-enabled sensors to provide continuous physiological monitoring during ablation procedure
Obviousness Reasoning
Real-time patient monitoring is a standard practice in medical interventions, and integrating IoT sensors represents a straightforward technological enhancement with expected improvements in treatment safety and efficacy
Source Patent Element
Ablation signals modulated at a common frequency
PTD Variation
Implementing blockchain-based secure data storage for treatment records and patient information
Obviousness Reasoning
Secure medical data management is a recognized industry requirement, and blockchain represents a known technological solution for ensuring data integrity and confidentiality
Source Patent Element
Applying composite signals using multiple electrodes
PTD Variation
Utilizing advanced materials-based electrodes with enhanced thermal characteristics
Obviousness Reasoning
Material science improvements in electrode design are a predictable area of medical device innovation, with finite identifiable approaches to reducing thermal spread and improving tissue contact
Source Patent Element
Control signals with different frequencies
PTD Variation
Implementing AI-powered predictive analytics to optimize ablation parameters
Obviousness Reasoning
Predictive modeling in medical interventions is a well-established technique, and applying machine learning to treatment parameter optimization represents a logical technological progression
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857245 and the disclosed variations, a person having ordinary skill in the art would find the integration of AI, IoT, blockchain, and advanced materials technologies into multi-channel RF ablation methodologies to be obvious and predictable extensions of existing medical device signal modulation techniques, thereby rendering potential patent claims in this domain obvious and unpatentable.

Original Patent Information

Patent NumberUS 11,857,245
TitleMulti-channel RF ablation
Assignee(s)Biosense Webster (Israel) Ltd.